Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

New York’s prison system is still in crisis, but funding for independent oversight by CANY was a key step forward. Now, proposed budget cuts threaten to undo these progress, despite CANY’s valuable ...